慢性阻塞性肺疾病临床诊断和治疗效果探讨

Investigation on clinical diagnosis and efficacy of chronic obstructive pulmonary disease

目的探讨慢性阻塞性肺疾病临床诊断和治疗方法。方法随机选取鄢陵县人民医院2012年3月至2014年7月收治的90例慢性阻塞性肺疾病患者，对患者的临床诊断方法进行回顾性分析，并按照治疗方案的不同将其分为实验组和对照组，其中实验组患者采用复方异丙托溴铵进行雾化治疗，对照组患者采用沙丁胺醇进行雾化治疗，对比两组患者的临床治疗效果。结果本研究共包括慢性阻塞性肺疾病重度患者13例，中度患者20例，轻度患者27例和30例危险倾向者；实验组临床治疗总有效率明显高于对照组，差异有统计学意义（P〈0．05）。结论对于慢性阻塞性肺疾病患者应结合患者的临床表现和检查结果及早准确诊断，采取有效措施控制患者病情的发展，其中复方异丙托溴铵雾化吸入是一种有效的治疗方案，建议在，临床上进一步推广使用。

Objective To investigate the clinical diagnosis and treatment effect of chronic obstructive pulmonary disease. Methods Ninety cases of patients with chronic obstructive pulmonary disease were selected, who were admitted in Yanling People＇s Hospital from March 2012 to July 2014. Their clinical diagnostic methods were retrospectively analyzed, and they were divided into experiment group and control group according to different treatment plans. Patients of experiment group were given nebulizer therapy with ipratropium, while patients of control group were given nebulizer therapy with albuterol. The clinical treatment effects of two groups were compared. Results The study included 13 patients with severe chronic obstructive pulmonary, 20 cases of moderate patients, 27 cases of mild patients and 30 cases of patients with dangerous tendencies. The overall effective rate of clinical treatment of patients in experiment group was significantly higher than that of the control group, the difference was significant （P 〈 0.05）. Conclusions For patients with chronic obstructive pulmonary disease, we should combine patients＇ clinical manifestations and findings, make accurate diagnosis as soon as possible and take effective measures to control development of patients＇ condition, in which compound ipratropium bromide aerosol inhalation is an effective treatment plan. It should be further popular- ized and used in clinical.